Microneedles for drug delivery

Connect therapy development with devices, microtechnology or delivery systems.

Microneedle array — CEA / AUBERT
Microneedle array — CEA / AUBERT
01Carnot instituteCEA-Leti
02Development stageExploratory / translational R&D
03Main expertiseMedical devices
04Relevant fieldsOncology, Dermatology / vaccines

Offer overview

What this offer helps you achieve

Connect therapy development with devices, microtechnology or delivery systems.

Scientific and technical scope

Microneedles for delivery of active substances through the skin. Some results of preclinical studies: for vaccines delivery, an equivalent immune system response at a dose ten times lower vs intramuscular injection; for skin cancers: active ingredient delivered to the most effective, deep layer of the dermis. Research areas Adapt biodegradable polymer specifications to match various active ingredients Define needle shape and spacing Semi-industrial cleanroom manufacturing processes Integrate optical measurement functions
01

Capabilities mobilised

Therapeutic areasMedical devices
02

Application fields

OncologyDermatology / vaccines

Discuss this offer

Could this capability strengthen your R&D programme?

Present your scientific, technical or clinical need and identify the most relevant route to collaboration.